Tentarix Biotherapeutics
PrivateLast Round
Series B
Sep 6, 2023
Total Funding Raised
$85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tentarix Biotherapeutics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in September 2023.
Tentarix Biotherapeutics is a biotechnology company that develops conditionally active, multispecific biologic therapies for oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tentarix Biotherapeutics Comparables
Compare Tentarix Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bonum Therapeutics | 87% | |
| Invenra | 85% | |
| Amberstone Biosciences | 83% |
For institutional investors. Book with your work email.
Tentarix Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 6, 2023 | ||||
| Series A | Oct 14, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tentarix Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Series B |
| Versant Ventures | Series B, Series A |
| Samsara BioCapital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 77% MoM.
- Mar 22, 2026
Ongoing partnered programs disclosed with Gilead and AbbVie.
For institutional investors. Book with your work email.
Tentarix Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tentarix Biotherapeutics's valuation, stock price, and market status.
Is Tentarix Biotherapeutics a public or private company?
Tentarix Biotherapeutics is a private company.
What is the current stock price of Tentarix Biotherapeutics?
Tentarix Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Tentarix Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tentarix Biotherapeutics worth (valuation)?
Valuation information for Tentarix Biotherapeutics is not publicly available.
Can I buy Tentarix Biotherapeutics stock?
Tentarix Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tentarix Biotherapeutics's last funding round?
Tentarix Biotherapeutics's most recent funding round was Series B on September 6, 2023.
Who are the main investors in Tentarix Biotherapeutics?
Key investors in Tentarix Biotherapeutics include Amplitude Ventures, Versant Ventures, Samsara BioCapital.
Will Tentarix Biotherapeutics IPO soon?
No public IPO plans have been announced for Tentarix Biotherapeutics.
How can I track Tentarix Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Tentarix Biotherapeutics's shares on secondary markets.